
    
      Multi-center observational study. Duration 12 months after the start of lumacaftor/ ivacaftor
      or tezacaftor/ ivacaftor .

      To collect these data and to assist in clinical decisions regarding initiation and
      continuation of lumacaftor/ivacaftor or tezacaftor/ ivacaftor, the investigators of the CF
      center (Beatrix Children's Hospital, University Medical Center Groningen (UMCG), the
      Netherlands) developed an extensive protocol of testing before children aged 6-18 years start
      therapy and during the first year after start.

      The protocol includes the following tests: growth parameters, sweat test, lung function
      testing (spirometry, MBW, body plethysmography), blood test panel (AST, ALT, alkalic
      phosphatase (AF), total and direct bilirubin, LDH), fecal elastase, high resolution (HR)CT
      and CF quality of life questionnaires. These tests are repeated at regular intervals.

      Multi-center observational study. Duration 12 months after the start of lumacaftor/ ivacaftor
      or tezacaftor/ ivacaftor .
    
  